General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 601: Which of the following factors prevents apoptosis in memory B cells?

A. Platelet-derived growth factor (PDGF)
B. Nerve growth factor (NGF) (Correct Answer)
C. Insulin-like growth factor (IGF)
D. Fibroblast growth factor (FGF)

Explanation: **Explanation:** The correct answer is **Nerve growth factor (NGF)**. Apoptosis is a highly regulated process of programmed cell death. In the immune system, memory B cells must survive for long periods to provide lasting immunity. This survival is mediated by specific survival signals that inhibit the apoptotic pathway [3]. **1. Why Nerve Growth Factor (NGF) is correct:** While traditionally associated with neuronal survival, NGF is also produced by follicular dendritic cells and T-cells within the germinal centers. Memory B cells express high-affinity NGF receptors (**TrkA**). The binding of NGF to these receptors upregulates the anti-apoptotic protein **Bcl-2**, thereby preventing the activation of caspases and ensuring the long-term survival of memory B cells. **2. Why the other options are incorrect:** * **PDGF (Platelet-derived growth factor):** Primarily involved in wound healing, angiogenesis, and the proliferation of connective tissue/mesenchymal cells (fibroblasts and smooth muscle cells). * **IGF (Insulin-like growth factor):** Acts as a potent mitogen and inhibitor of apoptosis in various somatic cells and skeletal muscle, but it is not the specific factor responsible for memory B cell maintenance. * **FGF (Fibroblast growth factor):** Involved in embryonic development, tissue repair, and hematopoiesis, but does not play a primary role in preventing apoptosis in the B cell memory compartment. **High-Yield Clinical Pearls for NEET-PG:** * **Bcl-2** is the "master" anti-apoptotic protein. Its overexpression (often via t(14;18) translocation) leads to **Follicular Lymphoma** by preventing B-cell death [1]. * **Fas (CD95)** is the "death receptor" involved in the extrinsic pathway of apoptosis, crucial for eliminating self-reactive lymphocytes [4]. * **BAX and BAK** are pro-apoptotic members of the Bcl-2 family that create pores in the mitochondrial membrane [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 310-311. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67.

Question 602: Histamine causes all the following except:

A. Arteriolar dilatation
B. Increased permeability of venules
C. Constriction of large arteries
D. Platelet aggregation (Correct Answer)

Explanation: **Explanation:** Histamine is a primary vasoactive amine stored in the granules of mast cells, basophils, and platelets. It is one of the first mediators released during an acute inflammatory response, primarily acting via **H1 receptors** on vascular smooth muscle and endothelial cells. **Why Option D is correct:** Histamine **does not cause platelet aggregation.** In fact, its primary role in inflammation is related to vascular changes [2]. Platelet aggregation is mediated by substances like Thromboxane A2 (TXA2), ADP, and Thrombin. While histamine is *stored* in platelets and released during their activation, it does not trigger the aggregation process itself. **Why the other options are incorrect:** * **A. Arteriolar dilatation:** Histamine is a potent vasodilator of arterioles [2]. This leads to increased blood flow to the site of injury, manifesting clinically as redness (rubor) and heat (calor). * **B. Increased permeability of venules:** This is the most characteristic effect of histamine [1]. It causes **endothelial cell contraction**, creating intercellular gaps specifically in the **post-capillary venules** [1]. This leads to protein leakage (exudate) and edema. * **C. Constriction of large arteries:** While histamine dilates small arterioles, it paradoxically causes the contraction of certain large arteries and non-vascular smooth muscle (like bronchial smooth muscle) [3]. **High-Yield Facts for NEET-PG:** * **Triple Response of Lewis:** Mediated by histamine, it consists of: 1. Red spot (capillary dilatation), 2. Flare (arteriolar dilatation), and 3. Wheal (exudation/edema) [2]. * **Site of Action:** Histamine-induced vascular permeability occurs **exclusively in the post-capillary venules**, not in capillaries or arterioles [1]. * **Stimuli for Release:** Physical injury, Type I hypersensitivity (IgE-mediated), and complement fragments (C3a and C5a, known as anaphylatoxins). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 187-188. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 101. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 94-95.

Question 603: All of the following are true about blood transfusion protocols EXCEPT:

A. Blood transfusions should commence within 60 minutes of removing the blood bag from refrigeration. (Correct Answer)
B. Whole blood or packed red blood cells must be transfused within 4 hours.
C. Transfusion sets should include a standard filter of 170 micrometers.
D. The usual needle size for blood transfusion is 18-19 gauge.

Explanation: **Explanation:** The correct answer is **A**. According to standard blood transfusion protocols (WHO and Red Cross guidelines), blood transfusion must commence within **30 minutes** of removing the blood bag from the refrigerator (stored at 2–6°C). If the transfusion cannot start within this window, the unit must be returned to the blood bank’s monitored refrigeration to prevent bacterial proliferation and loss of red cell viability. **Analysis of Options:** * **Option A (Incorrect Statement):** The 60-minute window is incorrect; the strict limit is 30 minutes to ensure the blood remains at a safe temperature. * **Option B (Correct Statement):** Once started, the transfusion of whole blood or PRBCs must be completed within **4 hours**. Prolonged exposure to room temperature increases the risk of septicemia due to potential bacterial growth. * **Option C (Correct Statement):** Standard blood administration sets must contain a **170–200 micrometer filter** to remove fibrin clots and debris that could cause microemboli. * **Option D (Correct Statement):** An **18–19 gauge needle** is standard for adults to ensure adequate flow rates and prevent hemolysis of red cells [3]. Smaller gauges (23G) may be used in pediatrics but require slower infusion. **High-Yield Clinical Pearls for NEET-PG:** * **Storage Temperature:** PRBCs (2–6°C), Platelets (20–24°C with agitation), FFP (-30°C or colder). * **Platelet Transfusion:** Must be completed within 20–30 minutes; never refrigerate platelets as it causes irreversible aggregation. * **Massive Transfusion:** Defined as replacing one total blood volume within 24 hours or 50% of blood volume within 3 hours [2]. * **Most Common Complication:** Febrile Non-Hemolytic Transfusion Reaction (FNHTR). * **Most Common Fatal Complication:** Transfusion-Related Acute Lung Injury (TRALI). * **ABO Incompatibility:** Acute hemolytic reactions most commonly stem from identification errors involving IgM antibodies [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 673-674. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 628-631. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 627-628.

Question 604: Which of the following is a classical example of transplacental carcinogenesis?

A. Teratoma
B. Primary squamous cell carcinoma of vagina
C. Sarcoma botryoids
D. Clear cell adenocarcinoma of vagina (Correct Answer)

Explanation: **Explanation:** The correct answer is **Clear cell adenocarcinoma of the vagina**. This is the classic medical example of **transplacental carcinogenesis** (prenatal exposure to a carcinogen leading to cancer later in life) [1]. **Why it is correct:** Between the 1940s and 1970s, **Diethylstilbestrol (DES)**, a synthetic estrogen, was prescribed to pregnant women to prevent miscarriages. It was later discovered that the female offspring (often called "DES daughters") had a significantly increased risk of developing **Clear cell adenocarcinoma of the vagina and cervix**, typically occurring in their late teens or early twenties [1]. The mechanism involves DES interfering with the normal transformation of glandular epithelium into squamous epithelium in the fetal vagina, leading to **vaginal adenosis**, which serves as a precursor to adenocarcinoma. **Why other options are incorrect:** * **A. Teratoma:** These are germ cell tumors containing tissues from all three germ layers [3]. While they can be congenital (e.g., Sacrococcygeal teratoma), they are not caused by transplacental chemical carcinogens. * **B. Primary squamous cell carcinoma of vagina:** This is the most common type of vaginal cancer in elderly women, primarily associated with high-risk **HPV (Human Papillomavirus)** infection and smoking, not fetal exposure [2]. * **C. Sarcoma botryoids (Embryonal rhabdomyosarcoma):** This is the most common vaginal tumor in infants and children (under age 5) [2]. It presents as a "grape-like" mass but is a sporadic mesenchymal tumor, not linked to transplacental DES exposure. **High-Yield Clinical Pearls for NEET-PG:** * **DES Exposure Triad:** Vaginal adenosis, Clear cell adenocarcinoma, and structural uterine abnormalities (T-shaped uterine cavity). * **Microscopy:** Clear cell adenocarcinoma characteristically shows **"Hobnail cells"** (cells with bulbous nuclei protruding into the lumen). * **Age Factor:** Unlike most vaginal cancers (elderly), clear cell adenocarcinoma occurs in young women (mean age ~19 years). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 223-224. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1004-1005. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 480-481.

Question 605: Thrombomodulin-thrombin complex produces its anticoagulant effect by?

A. Inactivating factors V and VIII (Correct Answer)
B. Inactivating protein C
C. Inactivating protein S
D. Inactivating factor VIII

Explanation: **Explanation:** The **Thrombomodulin-Thrombin complex** is a critical component of the natural anticoagulant system [1]. Under normal conditions, thrombin is a procoagulant enzyme. However, when thrombin binds to **Thrombomodulin** (an integral membrane protein on intact endothelial cells), its substrate specificity changes. 1. **Mechanism of Action:** The Thrombin-Thrombomodulin complex activates **Protein C** to form **Activated Protein C (APC)** [1]. 2. **The Anticoagulant Effect:** APC, along with its cofactor **Protein S**, proteolytically cleaves and **inactivates Factors Va and VIIIa** [1]. By neutralizing these essential cofactors in the coagulation cascade, the complex effectively halts further thrombin generation [1]. **Analysis of Options:** * **Option A (Correct):** As described, the ultimate downstream effect of the complex is the inactivation of Factors V and VIII via the Protein C pathway [1]. * **Option B (Incorrect):** The complex **activates** Protein C; it does not inactivate it. * **Option C (Incorrect):** Protein S acts as a cofactor for APC; it is not inactivated by the complex [1]. * **Option D (Incorrect):** While it does inactivate Factor VIII, this option is incomplete as it also inactivates Factor V [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Factor V Leiden:** A common genetic mutation where Factor V is resistant to cleavage by APC, leading to a hypercoagulable state (thrombophilia). * **Vitamin K Dependency:** Protein C and Protein S are Vitamin K-dependent; thus, Warfarin therapy initially causes a transient prothrombotic state due to the shorter half-life of Protein C compared to clotting factors [1]. * **Endothelial Integrity:** This mechanism explains why clots do not typically form on healthy, intact vascular endothelium. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-584.

Question 606: Isoprostanes are formed from archidonic acid by which mechanism?

A. Cyclooxygenase
B. Lipooxygenase
C. Epoxide hydrolase
D. Non-enzymatic free radical peroxidation (Correct Answer)

Explanation: **Explanation:** **Isoprostanes** are prostaglandin-like compounds that serve as highly sensitive and specific biomarkers of **oxidative stress**. **1. Why Option D is Correct:** Unlike prostaglandins, which are synthesized via enzymatic pathways, isoprostanes are formed by the **non-enzymatic, free radical-induced peroxidation** of arachidonic acid (and other polyunsaturated fatty acids) while they are still attached to membrane phospholipids. They are subsequently released by phospholipases and can be detected in plasma and urine. Because their formation is independent of enzymes and directly proportional to free radical activity, they are considered the "gold standard" for measuring lipid peroxidation in vivo. **2. Why Other Options are Incorrect:** * **Option A (Cyclooxygenase):** COX-1 and COX-2 enzymes are responsible for the enzymatic conversion of arachidonic acid into prostaglandins (PGE2, PGD2, etc.) and thromboxanes [1]. * **Option B (Lipooxygenase):** LOX enzymes (e.g., 5-LOX) convert arachidonic acid into leukotrienes and lipoxins [1]. * **Option C (Epoxide hydrolase):** This enzyme is involved in the metabolism of epoxides (like EETs) into diols; it is not involved in the primary peroxidation of arachidonic acid. **3. NEET-PG High-Yield Pearls:** * **Biomarker Status:** Isoprostanes (specifically **8-iso-PGF2α**) are the most reliable markers of oxidative stress in diseases like atherosclerosis, diabetes, and Alzheimer’s. * **Vasoactivity:** Unlike some prostaglandins, isoprostanes are potent **vasoconstrictors** (especially in renal and pulmonary vasculature). * **Membrane Damage:** Their formation is a hallmark of **irreversible cell injury** caused by reactive oxygen species (ROS). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 95.

Question 607: Mitochondrial abnormality is seen in which of the following conditions?

A. Krabbe's disease
B. Fabry disease
C. Fanconi syndrome
D. Oncocytoma (Correct Answer)

Explanation: **Explanation:** **Oncocytoma** is the correct answer because it is a benign epithelial tumor characterized by the presence of **oncocytes**. These are large, polygonal cells with abundant, granular, eosinophilic cytoplasm. This characteristic appearance is due to the **massive accumulation of mitochondria** within the cell. On electron microscopy, the cytoplasm is literally packed with mitochondria of varying sizes and shapes, often showing abnormal cristae. This mitochondrial proliferation is thought to be a compensatory mechanism for defects in the mitochondrial respiratory chain. **Analysis of Incorrect Options:** * **Krabbe’s Disease:** This is a **lysosomal storage disorder** (specifically a leukodystrophy) caused by a deficiency of the enzyme galactocerebrosidase, leading to the accumulation of galactocerebroside in the brain [1]. * **Fabry Disease:** This is an X-linked **lysosomal storage disorder** caused by a deficiency of alpha-galactosidase A, leading to the accumulation of globotriaosylceramide (Gb3). * **Fanconi Syndrome:** This is a disorder of the **proximal renal tubules** where substances (glucose, amino acids, etc.) are excreted into the urine instead of being reabsorbed. While it can be secondary to mitochondrial diseases, the syndrome itself is a functional tubular defect, not a primary mitochondrial structural abnormality like oncocytoma. **High-Yield Clinical Pearls for NEET-PG:** * **Oncocytoma Locations:** Most commonly found in the **kidney** (Renal Oncocytoma) and **salivary glands** (Warthin’s tumor also contains oncocytes). * **Radiology:** Renal oncocytomas often show a characteristic **"stellate central scar"** on CT/MRI. * **Histology:** The granular eosinophilia is "PAS negative" (unlike clear cell carcinoma which is PAS positive due to glycogen). * **Mnemonic:** Remember **"Onco" = "Mighty" (Mitochondria)**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1304-1305.

Question 608: What is the most common cause of cell injury?

A. Hypoxia (Correct Answer)
B. Ischemia
C. Carbon monoxide poisoning
D. Anemia

Explanation: **Explanation:** **1. Why Hypoxia is the Correct Answer:** Hypoxia, defined as a deficiency of oxygen, is the **most common cause of cell injury** in clinical practice. Oxygen is the terminal electron acceptor in oxidative phosphorylation; its absence leads to the failure of ATP production [1]. This energy failure disrupts the Na+/K+ pump, leading to cellular swelling (hydropic change), which is the first manifestation of almost all forms of cell injury [1]. **2. Analysis of Incorrect Options:** * **Ischemia (Option B):** While ischemia (reduced blood supply) is the **most common cause of hypoxia** in clinical settings, it is considered a *subset* of hypoxia. Hypoxia is the broader, overarching mechanism of injury [1]. Note: Ischemia is often more damaging than pure hypoxia because it also prevents the delivery of nutrients (glucose) and the removal of metabolic wastes [1]. * **Carbon Monoxide (CO) Poisoning (Option C):** This is a specific cause of hypoxia (anemic hypoxia) where CO binds to hemoglobin with high affinity, preventing oxygen transport. It is a classic exam example but not the most common cause overall. * **Anemia (Option D):** This results in a reduced oxygen-carrying capacity of the blood. Like CO poisoning, it is a specific etiology leading to hypoxia, but it is statistically less frequent as a primary cause of acute cell injury compared to generalized hypoxic states. **3. NEET-PG High-Yield Pearls:** * **Most common cause of cell injury:** Hypoxia. * **Most common cause of hypoxia:** Ischemia. * **First sign of cell injury (Light Microscopy):** Cellular swelling (Hydropic change/Vacuolar degeneration) [1]. * **First sign of cell injury (Electron Microscopy):** Mitochondrial swelling and ER dilation [1]. * **Irreversible injury hallmark:** Severe mitochondrial damage and membrane rupture (lysosomal/plasma membrane) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 49-62.

Question 609: Fat necrosis is not associated with which of the following procedures or conditions?

A. Liposuction
B. Mammoplasty
C. Carcinoma of the breast (Correct Answer)
D. Trauma

Explanation: Enriched Explanation: Fat necrosis is a form of cell death specifically involving adipose tissue, characterized by the action of lipases or physical disruption of adipocytes [1]. **Why Carcinoma of the Breast is the correct answer:** Fat necrosis is a **benign** inflammatory process. While fat necrosis can clinically mimic breast cancer (presenting as a painless, hard, fixed mass), it is not a feature or a result of the carcinoma itself. Carcinoma of the breast involves the malignant proliferation of epithelial cells (ductal or lobular), which typically leads to a "desmoplastic reaction" (fibrosis) rather than enzymatic or traumatic fat necrosis. **Analysis of Incorrect Options:** * **Liposuction & Mammoplasty:** These are surgical procedures that involve mechanical trauma and disruption of the blood supply to subcutaneous fat. This leads to the release of intracellular lipids, triggering an inflammatory response and subsequent fat necrosis. * **Trauma:** Physical injury is the most common cause of fat necrosis in the breast and extremities. The rupture of adipocytes releases neutral fats, which are then phagocytosed by macrophages (foam cells), leading to characteristic "oil cysts" or calcification. **NEET-PG High-Yield Pearls:** * **Microscopic Appearance:** Look for "shadowy outlines" of necrotic adipocytes with lost nuclei, surrounded by an inflammatory infiltrate and **foamy macrophages** [1]. * **Saponification:** In acute pancreatitis (enzymatic fat necrosis), released fatty acids combine with calcium to form chalky white deposits, a process known as saponification [1]. * **Clinical Mimicry:** On mammography, fat necrosis often shows **eggshell calcification**, which helps differentiate it from the irregular microcalcifications seen in malignancy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 55.

Question 610: Which of the following statements about the P53 gene is incorrect?

A. It can arrest the cell cycle at the G1 phase.
B. Its product is a 53 kDa protein.
C. It is located on chromosome 17.
D. The wild-type, non-mutated form is associated with an increased risk of childhood tumors. (Correct Answer)

Explanation: **Explanation:** The **TP53 gene**, often referred to as the "Guardian of the Genome," is a tumor suppressor gene that plays a critical role in maintaining genomic stability [2]. **Why Option D is the correct (incorrect statement):** The **wild-type (normal)** form of P53 is essential for preventing tumor formation. It acts as a molecular policeman that monitors DNA damage. An increased risk of tumors, such as in **Li-Fraumeni Syndrome**, occurs only when the gene is **mutated or deleted**, not when it is in its wild-type state [1]. **Analysis of other options:** * **Option A:** P53 can indeed arrest the cell cycle at the **G1 phase** [1]. Upon detecting DNA damage, P53 induces the transcription of **p21** (a CDK inhibitor), which prevents the cell from entering the S phase, allowing time for DNA repair [2]. * **Option B:** The gene is named P53 because its protein product has a molecular weight of **53 kiloDaltons (kDa)**. * **Option C:** The TP53 gene is located on the short arm of **chromosome 17 (17p13.1)** [1]. **High-Yield NEET-PG Pearls:** 1. **Mechanism of Action:** If DNA repair fails, P53 triggers apoptosis by upregulating pro-apoptotic genes like **BAX** and **PUMA** [2]. 2. **Li-Fraumeni Syndrome:** A germline mutation of TP53 leading to a high frequency of diverse cancers (Sarcoma, Breast, Leukemia, Adrenal - **SBLA** syndrome). 3. **Degradation:** In healthy cells, P53 levels are kept low by **MDM2**, which facilitates its degradation via the ubiquitin-proteasome pathway. 4. **Most Common Mutation:** TP53 is the most frequently mutated gene in human cancers (>50% of all cases) [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-304.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free